Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tempol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 46Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Latest biotech merger sees aimless Adamis snapped up by DMK
    Latest biotech merger sees aimless Adamis snapped up by DMK

    28 Feb 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/latest-biotech-biotech-merger-sees-aimless-adamis-snapped-dmk

    James Waldron FIERCE BIOTECH
    28 Feb 2023
    Share Share
    Adamis’ shares nosedive as sole clinical-stage asset flunks COVID-19 trial
    Adamis’ shares nosedive as sole clinical-stage asset flunks COVID-19 trial

    22 Sep 2022

    // James Waldron FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/adamis-shares-nosedise-sole-unapproved-asset-flunks-covid-trial

    James Waldron FIERCEBIOTECH
    22 Sep 2022
    Share Share
    Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive
    Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive

    21 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/21/2520081/32832/en/Adamis-Provides-Update-on-the-Phase-2-3-Trial-of-Tempol-in-COVID-19-Positive-High-Risk-Subjects.html

    GLOBENEWSWIRE
    21 Sep 2022
    Share Share
    Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol
    Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol

    13 Sep 2022

    // PRESS RELEASE

    https://ir.adamispharmaceuticals.com/news-releases/news-release-details/adamis-provides-enrollment-update-phase-23-study-tempol-covid-19

    PRESS RELEASE
    13 Sep 2022
    Share Share
    Adamis to continue Phase II/III trial of Tempol for Covid-19
    Adamis to continue Phase II/III trial of Tempol for Covid-19

    02 Jun 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/adamis-trial-tempol-covid/

    CLINICALTRIALSARENA
    02 Jun 2022
    Share Share
    Adamis Doses 1st Patient in Phase 2/3 Clinical Trial for Tempol in COVID-19
    Adamis Doses 1st Patient in Phase 2/3 Clinical Trial for Tempol in COVID-19

    02 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/02/2290774/32832/en/Adamis-Pharmaceuticals-Doses-First-Patients-in-Phase-2-3-Clinical-Trial-for-Tempol-in-the-Treatment-of-COVID-19.html

    GLOBENEWSWIRE
    02 Sep 2021
    Share Share